Limited Competition: Nonhuman Primate (NHP) Radiation Survivor Cohort (RSC) (U01 Clinical Trial Not Allowed)
The summary for the Limited Competition: Nonhuman Primate (NHP) Radiation Survivor Cohort (RSC) (U01 Clinical Trial Not Allowed) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Limited Competition: Nonhuman Primate (NHP) Radiation Survivor Cohort (RSC) (U01 Clinical Trial Not Allowed): The purpose of this limited competition Funding Opportunity Announcement (FOA) is to support continued care for and conduct of specialized research using a unique nonhuman primate (NHP) population. Specifically, the preservation, medical monitoring, study, treatment, and intervention in the development of late effects in NHP survivors of radiation exposure. NHPs most closely resemble human responses to radiation exposure and, as such, long-term studies on a radiation survivor cohort will permit continuous observations and treatment of this valuable population, while providing a critical understanding of the natural history of radiation exposures, including early and late injuries and disease development. The successful applicant must have facilities and staff to care for a combined minimum of 120 irradiated and unirradiated control NHPs, exposed at various ages and available for study, and must be able to accommodate receipt of additional radiation-exposed animals from other government-supported studies.
Federal Grant Title: | Limited Competition: Nonhuman Primate (NHP) Radiation Survivor Cohort (RSC) (U01 Clinical Trial Not Allowed) |
Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-AI-19-010 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.855 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | May 31st, 2019 |
Original Application Deadline: | May 31st, 2019 |
Posted Date: | February 25th, 2019 |
Creation Date: | February 25th, 2019 |
Archive Date: | July 6th, 2019 |
Total Program Funding: | $3,000,000 |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | 1 |
Cost Sharing or Matching: | No |
Last Updated: | February 25th, 2019 |
- Applicants Eligible for this Grant
- Public and State controlled institutions of higher education
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. See FOA for full eligibility details.
- Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-19-010.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster - Similar Government Grants
- • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
- • Immunobiology of Xenotransplantation (U19 Clinical Trial Not Allowed)
- • Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Anti...
- • Immunobiology of Xenotransplantation (U01 Clinical Trial Not Allowed)
- • Limited Interaction Targeted Epidemiology: Epidemiology of Transmission and Treatment of H...
- • Center for HIV/AIDS Vaccine Immunology (CHAVI)
- • Genomics of Transplantation Cooperative Research Program
- • Asthma and Allergic Diseases Cooperative Research Centers
- More Grants from the National Institutes of Health
- • SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies...
- • Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Al...
- • Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional)
- • Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial No...
- • Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimenta...